These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients. Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
7. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor. Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458 [TBL] [Abstract][Full Text] [Related]
8. A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy. Lui DTW; Lee ACH; Yap DYH; Chan GSW; Tan KCB J Clin Lipidol; 2019; 13(2):251-253. PubMed ID: 30685233 [TBL] [Abstract][Full Text] [Related]
9. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure]. Kuwabara Y; Komuro I Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):255-61. PubMed ID: 15768589 [No Abstract] [Full Text] [Related]
11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
12. Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: a one-year randomized study of valsartan versus enalapril. Ko GT; Tsang CC; Chan HC Adv Ther; 2005; 22(2):155-62. PubMed ID: 16020405 [TBL] [Abstract][Full Text] [Related]
13. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis. Bozkurt D; Cetin P; Sipahi S; Hur E; Nar H; Ertilav M; Sezak M; Duman S Perit Dial Int; 2008 Nov; 28 Suppl 5():S38-42. PubMed ID: 19008539 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of valsartan versus enalapril in heart failure patients. Willenheimer R; Helmers C; Pantev E; Rydberg E; Löfdahl P; Gordon A; Int J Cardiol; 2002 Oct; 85(2-3):261-70. PubMed ID: 12208593 [TBL] [Abstract][Full Text] [Related]
15. Valsartan: more than a decade of experience. Black HR; Bailey J; Zappe D; Samuel R Drugs; 2009; 69(17):2393-414. PubMed ID: 19911855 [TBL] [Abstract][Full Text] [Related]
16. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521 [TBL] [Abstract][Full Text] [Related]
17. Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation. Osugi Y; Yamada H; Hosoi G; Noma H; Ikemiya M; Ishii T; Sako M Int J Hematol; 2006 Jun; 83(5):454-8. PubMed ID: 16787879 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3. Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707 [TBL] [Abstract][Full Text] [Related]
19. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548 [TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]